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**O**steoporosis is a significant public health challenge that is characterized by skeletal disorder with compromised bone strength which results from the decrease in bone mineral density (BMD).^[@ref1]^ The mass destruction in microstructures of bone tissue is closely observed as it might result in an increase in the risk of bone fracture.^[@ref4],\ [@ref5]^ Osteoporosis is the most prevalent age related bone metabolic disorder which, subsequently, predisposes to an increased risk of fracture that, in turn, leads to disability of the individual and causes high costs to society.^[@ref6]^ Hip fractures burden, actually, with 1% on total leg fractures. Factors such as race, physical activity, body composition, the amount of calcium and Vitamin-D intake are responsible for osteoporosis in males.^[@ref9]^ Estrogen hormone is particularly efficacious in skeletal development, maintenance of Bone Mineral Density (BMD) and prevention of fractures.^[@ref10]^ In most postmenopausal women, serum estradiol level decreases and reaches about 10% of the value before menopause. Rapid decrease in BMD and progression of osteoporosis occurs in most women without any replacement.^[@ref11],[@ref12]^ Although the influence of estradiol is more significant on women, low concentration of 17-beta-estradiol is associated with reduction of cortical thickness of long bones in aged men.^[@ref13],[@ref14]^ Several surveys have shown that there is a direct relation in BMD between testosterone and estradiol levels.^[@ref15]^ Our study is focused on the association between total serum estradiol level and fracture risk of femoral neck in patients referred to the two university hospitals of Imam Reza and Hasheminejad.

Materials and Methods {#sec1-1}
=====================

The ethics committee of Mashhad University of Medical Sciences approved protocol of this study and a written informed consent was taken from all subjects. Men of over 50 years with fracture of femoral neck without low BMD were the sample size for this study. Considering the aims of the study, at least 120 subjects were required to perform statistical tests with the power of 80%. 120 random men over 50 years admitted to Imam Reza and Hasheminejad hospitals of Mashhad were entered into the study. The sample size measurement was calculated with Number Cruncher Statistical & Power Analysis and Sample Size (NCSS&PASS). The subjects were classified into two groups (60 for the case and 60 for the control group). Serum estradiol level was measured based on the ELISA method. Based on the estradiol level, the subjects were divided into adequate (≤10pg/ml) and deficient (≥9pg/ml) levels. Men older than 50 years without neck of femure fracture were evaluated for the concentration of estradiol and were divided into adequate and deficient groups. This cut-off point was defined based on the levels associated with the risk for osteoporotic fracture; thus, levels above 10 are considered adequate and higher levels which are hyperestrogenemia were not separated. Patients with the previous history of femur's fracture, known pathologic problems in femur (e.g. tumors and cysts), and history of treatment with corticosteroids were excluded from the study. Data gathering consisted of the following variables: age and weight. The history of age of the two groups was defined as below 65 and over 65 years old; the weights of the groups were: below 80 and over 80 kilograms and the last groups were smoking and no-smoking. Serum estradiol level was measured based on the ELISA method. Independent sample T test was used to compare age and weight of the patients and control groups. Pearson chi-square and logistic regression were performed to evaluate the results. Multivariate regression analysis was utilized to evaluate the role of factors in predicting serum estradiol levels. Significance level was considered as P-values lower than 0.05. Statistical analysis was carried out using SPSS version 17.

Results and Discussion {#sec1-2}
======================

Case-control study consisted of 120 individuals older than 50 years. It included 60 cases of accidental femoral fracture. 60 men older than 50 years without femoral fracture were entered into the control group. The mean age in patients and control groups was 69.5±8.84 and 67.9±10.22 respectively (p=0.376). The mean weight of the patients' and control groups was 67.7± 12.49Kg and 68.4±11.79Kg respectively (P=0.776) ([Table 1](#table001){ref-type="table"}). The percentage of smokers in patient and control groups was 31% and 35%, respectively (P=0.699) ([Table 2](#table002){ref-type="table"}). The frequency of adequate and deficient estradiol levels was compared among the patients and control groups. There was no significant difference between patients with low serum estradiol level and femur's fracture following mild trauma and patients without hip fracture or with a history of hip fracture ([Table 3](#table003){ref-type="table"}). According to the multivariate regression analysis, the only significant factor in predicting serum estradiol level was smoking ([Table 4](#table004){ref-type="table"}). This study showed that there is no significant difference between patients with low estradiol level and a fracture following mild trauma and persons without femoral fracture or a history of hip fracture. In other words, femur's fracture was not the result of low level of serum estradiol and the association of etsradiol-hip fracture is inconsistent and probably related to multifactorial causes of hip-fracture risk. Consistent with our study, several studies reported that there is no association between low estradiol and fracture risk in men.^[@ref20]^ Bojenerem et al found that there was no effect of estradiol on fracture risk; and sex steroids could not predict the risk of non-vertebral fracture.^[@ref20]^ Legrand et al showed that there was no significant difference in estradiol level between osteoporotic men and controls. Results of their study showed that estradiol levels do not correlate with bone formation or bone reabsorption markers.^[@ref23]^ In addition, Channing et al, in a cross sectional study of US population, evaluated 1185 adult men. They did not observe any association between total estradiol (E2) and BMD in men.^[@ref24]^ However, there were several studies that revealed the association between low serum estradiol levels and fracture risk in women,^[@ref25]^ and men,^[@ref26]^ thereby making the probable impact of sex steroids on fracture risk unclear.^[@ref29]^ Fink et al, in a large longitudinal analysis, presented that old men with low BMD-osteoporosis in the femur neck were more likely to have estradiol deficiency.^[@ref30]^ Szulc et al showed that the low levels of estradiol-E2 were negatively correlated with BMD in men over 50 years old.^[@ref27]^ Fracture risk for men in the first quartile of serum estradiol-17 E2 was 50-100% higher than men with the highest quartile of 17 E2.^[@ref27],[@ref31]^ In addition, the influence of low estradiol level on BMD is strengthened if associated with low testosterone and high Sex Hormone Binding Globulin levels.^[@ref27]^ In contrast with our study, BMD is a more accurate measure of bone health compared with fracture of femoral neck.^[@ref30]^ Woo et al. claimed that the most powerful association was between total estradiol and femoral BMD, and osteoporosis was mostly observed in men with estradiol level \<18.8pg/ml. A strong relationship was observed in non-vertebral fractures (hip, radius, and arm). After adjustment for BMD, there was not any significant relationship between total estradiol and femoral fracture.^[@ref31]^ In many of the previous studies, the correlation between sex steroids and fracture risk was attenuated after adjusting for BMD,^[@ref32]^ and, as far as we know, estradiol as predictive signal in relation to BMD was not found in recent studies. Most studies, actually, emphasized the effect of estradiol on bone mineral density as an endpoint.^[@ref7],[@ref20],[@ref21],[@ref29],[@ref31]^ Mellstrom et al. evaluated 2639 Swedish old men over 3.3 years and according to a multivariable regression analysis; free estradiol was independently associated with vertebral, non-vertebral and hip fracture risk.^[@ref28]^ Until now, in most studies, the inverse correlation between estradiol level and fracture risk was revealed only below a specific cut-point of serum estradiol. It appeared that there was a serum estradiol threshold below which fracture risk tend to increase; above this level there is no correlation between the estradiol level and fracture risk.^[@ref23],[@ref27],[@ref30]^ According to most study, there is a nonlinear relationship between total estradiol-E2 and fracture risk below dichotomous cut-off point of estradiol (12 and 16pg/ml).^[@ref29]^ To our knowledge, the minimal level of estradiol was required for osteocyte bioavailability. In addition, serum estradiol levels were higher in men compared with postmenopausal women; men being well above the minimal required level for bone health.^[@ref32]^ There are several other explanations that supported the absence of any association between femoral fracture risk and sex steroids. Limited number of fractures and reliance on immunoassays with inadequate accuracy in low concentrations might explain our negative results. Single measurement of estradiol does not properly reflect long term exposure to estradiol deficiency.^[@ref20]^ Furthermore, femoral fracture seems to be less related to bone fragility than vertebral fractures.^[@ref32]^ In summary, although several studies suggested that higher fracture rates were linked to lower estradiol levels, there were few publications that do not support the hypothesis in agreement with our data.^[@ref33]^ This study had some limitations. Our results from a retrospective study were difficult to interpret. One of the most important limitations of our study was the relatively low number of patients in our study. In addition, the subjects do not reflect the entire populations; therefore, our negative results might be due to low statistical power. Hormonal status determination by a single measurement for estradiol level could have diluted the correlation. Measurement of estradiol was not performed by gold standard methods (liquid chromatography/mass spectrophotometry); thus, we will reinforce the study with highly sensitive techniques. In addition, we did not consider co-morbidity that could affect estradiol levels. There were several confounders factors like BMI that were not evaluated. In addition, it seems that femoral neck fracture was not a good criterion for osteoporosis in contrast with BMD in other studies.^[@ref30]^ Moreover, in the last decade, most studies evaluated the association between additional factors like serum level of biological estradiol, sex hormone binding globulin, testosterone, aromatase enzyme activity and bone mineral density.^[@ref34]^ In general, despite several evidences that supported the positive effect of sex steroid on bone metabolism in experimental animal models, clinical studies have not confirmed their independent predictive role in bone fracture.^[@ref34]^ In conclusion, there was no clear association between estradiol serum level and fracture risk in old men. Our analysis was not helpful to assess whether fracture risk was estradiol dependent. Other community-based studies with larger sample sizes and standardized methods for sex steroid are required to confirm it. However, the study confirmed the value of using BMD to evaluate bone health status.

This study was a thesis of Dr. Mohammad Farrokhfar for the degree in Specialization in post-lauream School in emergency medicine, under the supervision of Professor Amir Masoud Hashemian and with Professor Kooroosh Ahmadi as his adviser. Funding: None.

NCSS&PASS

:   Number Cruncher Statistical & Power Analysis and Sample Size

BMD

:   Bone Mineral Density

ELISA

:   Enzyme-linked Immunosorbent Assay

###### 

Age and weight characteristics of study participants

           Patients group   Control group   P value
  -------- ---------------- --------------- ---------
           Mean±SD          Mean±SD         
  Age      69.5±8.84        67.7±10.29      0.376
  Weight   67.7±12.49Kg     68.4±11.79Kg    0.776

###### 

Simple correlation of cigarette smoking (%) with fracture risk

  cigarette smoking   Yes       no          
  ------------------- --------- ------ ---- ------
  Patient group       19        31.7   41   68.3
  Control group       21        35     39   65
  Total               40        33.3   80   66.7
  P value             p=0.699               

###### 

Simple correlation of estradiol (%) level with fracture risk

  Estradiol level   ≤9pg/ml   ≥10pg/ml         
  ----------------- --------- ---------- ----- ------
  Case group        6         10         54    90
  Control group     10        83.3       50    83.3
  Total             16        86.7       104   86.7
  P value           P=0.263                    

###### 

Association between smoking (%) and serum estradiol level

  Estradiol level Smoking   9 pg/ml and lower   10 pg/ml and higher         
  ------------------------- ------------------- --------------------- ----- ------
  Yes                       9                   22.5                  31    77.5
  No                        7                   8.8                   73    91.3
  Total                     16                  13.3                  104   86.7
  P value                   P=0.037                                         
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